Scale-up/Technology Transfer
- All
- APIs
- Aseptic Processing
- cGMP Manufacture
- Cleaning Validation
- Clinical Trial Materials
- Cytotoxics and High Potency Manufacturing
- Excipients
- Extractables and Leachables
- Facilities
- Fill/Finish
- Lyophilization
- Parenterals
- Process Development
- Process Validation
- Risk Management
- Scale-up/Technology Transfer
- Solid Dosage/Creams/Ointments
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
Rentschler, Horizon Ink Cell Line Development Pact
The alliance aims to drive efficiencies in biotherapeutic manufacturing from early drug development through commercial manufacturingContract Pharma Staff 05.19.20
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Scale-up/Technology Transfer
The Next Evolution of Biomanufacturing Technology
NevoLine platform offers solutions for various applications such as viral vaccines, gene therapies, and oncolytic virusesVideos
-
Breaking News | cGMP Manufacture | Drug Development | Drug Discovery | Industry News | Scale-up/Technology Transfer
BioMed X Launches Rapid Antiviral Response Platform
Aims to develop ultrafast new antiviral drug discovery, development and mass-manufacturing tools for rapid scale-up of new medications.Contract Pharma Staff 05.13.20
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Scale-up/Technology Transfer
Reinventing Benchtop Viral Production
Scale-X carbo bioreactor is a bench-scale automated cell culture system for expression and concentration of viral drug substanceVideos
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News | Scale-up/Technology Transfer
Thermo Fisher Scientific Expands Viral Vector Mfg. Capacity
$180M project will more than double commercial capacity in Plainville, MA to support the development and manufacture of gene therapies and vaccines.Contract Pharma Staff 05.11.20
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Scale-up/Technology Transfer
Univercells Launches Bioprocess Technologies Subsidiary
Will focus on the development and commercialization of intensified, automated biomanufacturing technologies.Infographics
-
Bio News | Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Scale-up/Technology Transfer
NJII Names BioCentriq as Cell & Gene Therapy Mfg. Center
Newark, NJ process development and clinical manufacturing facility for cell and gene therapies becomes first of its kind located on a U.S. university campus.Videos
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer
NJII Launches BioCentriq Cell & Gene Therapy Mfg. Center
Process development and clinical manufacturing facility for cell and gene therapies becomes first of its kind located on a U.S. university campus.Contract Pharma Staff 05.05.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Scale-up/Technology Transfer
Univercells Launches Bioprocess Technologies Subsidiary
Will focus on the development and commercialization of intensified, automated biomanufacturing technologies.Contract Pharma Staff 05.05.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Scale-up/Technology Transfer
Moderna, Lonza Enter COVID-19 Vaccine Mfg. Pact
Aims to enable manufacturing of up to 1 billion doses per year with first batches of mRNA-1273 expected to be manufactured at Lonza U.S. in July 2020Contract Pharma Staff 05.01.20
-
Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
Catalent, J&J Enter Mfg. Pact for COVID-19 Vax Candidate
Includes joint investment and tech transfer to prepare for rapid scale-up and cGMP commercial manufacturing at Catalent's Bloomington facility.Contract Pharma Staff 04.29.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
Jenner Institute, MilliporeSigma to Scale Up Covid-19 Vax Production
Develops a rapid, scalable platform following good manufacturing practices and using disposable technologies.Contract Pharma Staff 04.14.20
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trials | Drug Development | Scale-up/Technology Transfer
Rapid Delivery of Medical Countermeasures Amid Pandemic
Robert Erwin of iBio discusses the company’s COVID-19 vaccine development efforts and FastPharming manufacturing platform for the rapid delivery of vaccinesOnline Exclusives Kristin Brooks, Contract Pharma 04.03.20
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Scale-up/Technology Transfer
Robust Response to COVID-19 Demand
What it’s going to take to develop, scale-up, and manufacture the products needed to address the COVID-19 outbreak.Christa Myers, Pharmaceutical Market Sector Lead, CRB 03.31.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trials | Industry News | Scale-up/Technology Transfer
Cobra Biologics Joins COVID-19 Consortium
Aims to rapidly develop, scale-up and produce potential adenoviral vaccine candidate for COVID-19.03.31.20
-
Bio News | Breaking News | cGMP Manufacture | Scale-up/Technology Transfer
Sartorius Supports Coronavirus Vax Candidate
BIOSTAT STR single-use bioreactor system used for the upstream preparation of the recombinant vaccine03.25.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Scale-up/Technology Transfer
Lonza Launches TheraPEAK SfAAV Medium
Designed specifically for production of Adeno Associated Virus (AAV) in Spodoptera Fuigiperda (Sf9) insect cells for gene therapy applications03.23.20
-
Breaking News | cGMP Manufacture | Drug Development | Industry News | Laboratory Testing | Scale-up/Technology Transfer
Thermo Fisher Scientific Continues Biopharma Investments
Further invests $475 million in biopharma capabilities to help accelerate commercialization03.23.20
-
Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
Bright Path Labs Accepted into FDA's Emerging Technology Program
Scalable continuous manufacturing technology paves way for rapid, low-cost domestic API production03.19.20
-
Breaking News | Clinical Trial Materials | Drug Development | Industry News | Scale-up/Technology Transfer
USP Offers Support for COVID-19 Antiviral/Vax Developers
Aims to help developers ensure quality of their materials as they scale up manufacturing to bring products into clinical development.03.19.20
